Articles by Wade Aubry, MD
Improving Patient-Centered Care in Diabetes With Comparative Effectiveness Research
ByDouglas K. Owens, MD,Wade Aubry, MD,Roy Beck, MD,Joshua Benner, MD,Jan E. Berger, PharmD,Michael E. Chernew, PhD,Felicia Forma, BSc,Dana P. Goldman, PhD,William H. Herman, MD,Rebecca Killion, MA,Darius Lakdawalla, PhD,Anne L Peters, MD Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes
ByMichael E. Chernew, PhD,Rick McKellar, BS,Wade Aubry, MD,Roy Beck, MD, PhD,Joshua Benner, PharmD, ScD,Jan E. Berger, MD, MJ,A. Mark Fendrick, MD,Felicia Forma, BSc,Dana Goldman, PhD,Anne Peters, MD,Rebecca Killion, MA,Darius Lakdawalla, PhD,Douglas K. Owens, MD,Joe Stahl, MA Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes
ByMichael E. Chernew, PhD,Rick McKellar, BS,Wade Aubry, MD,Roy Beck, MD, PhD,Joshua Benner, PharmD, ScD,Jan E. Berger, MD, MJ,A. Mark Fendrick, MD,Felicia Forma, BSc,Dana Goldman, PhD,Anne Peters, MD,Rebecca Killion, MA,Darius Lakdawalla, PhD,Douglas K. Owens, MD,Joe Stahl, MA Formularies of the future should use evidence-produced CER to better target, not limit, diabetes care.